Investors with a lot of money to spend have taken a bearish stance on AbbVie ABBV.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ABBV, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 24 uncommon options trades for AbbVie.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 50%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $105,465, and 21 are calls, for a total amount of $1,655,712.
Expected Price Movements
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $210.0 for AbbVie over the recent three months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $150.0 to $210.0 in the last 30 days.
AbbVie Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | TRADE | BEARISH | 04/17/25 | $4.7 | $4.55 | $4.56 | $195.00 | $615.5K | 546 | 1.4K |
| ABBV | CALL | TRADE | BULLISH | 02/07/25 | $15.5 | $14.2 | $15.3 | $175.00 | $84.1K | 225 | 171 |
| ABBV | CALL | TRADE | BEARISH | 02/07/25 | $16.1 | $14.6 | $15.15 | $175.00 | $83.3K | 225 | 61 |
| ABBV | CALL | TRADE | BEARISH | 02/07/25 | $10.9 | $10.1 | $10.1 | $180.00 | $77.7K | 529 | 22 |
| ABBV | CALL | TRADE | NEUTRAL | 02/07/25 | $16.85 | $16.2 | $16.58 | $172.50 | $72.9K | 200 | 45 |
About AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Following our analysis of the options activities associated with AbbVie, we pivot to a closer look at the company's own performance.
Present Market Standing of AbbVie
- Trading volume stands at 4,545,253, with ABBV's price up by 3.15%, positioned at $189.7.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 81 days.
What Analysts Are Saying About AbbVie
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $208.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * An analyst from Raymond James has revised its rating downward to Outperform, adjusting the price target to $220. * Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on AbbVie with a target price of $190. * An analyst from Truist Securities has decided to maintain their Buy rating on AbbVie, which currently sits at a price target of $211. * An analyst from Citigroup has decided to maintain their Buy rating on AbbVie, which currently sits at a price target of $205. * Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on AbbVie with a target price of $217.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AbbVie, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
